MiDROPS® (Microemulsion Drug Ocular Penetration System)

As Co-Founder and Chief Commercial Officer at Microverse Studios, Olivia Slayden brings her innovative perspective to the team, constantly challenging the status quo to differentiate Microverse Studios in a competitive medical communications landscape. She is recognized for her strategic thinking, attention to detail, and creative problem-solving. In her spare time, Olivia loves staying updated on industry trends and sharing her insights through the Microverse Studios blog.

in